Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 168 participants.
Also called NCT01444248
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 168 participants
- Sponsor
- Registry
-
NCT01444248
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01444248. Randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2011-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Glimepiride/ Metformin
- Intervention (Drug)
- Glimepiride/ Metformin
- Lead sponsor
- Handok Inc.
Record details
- Record id
cardio:ct-nct01444248- Content hash
77350ab6ee1e828379c7d9ef53ddf85493b6677020564db02725b8834b9f437d